Ming‐Sound Tsao

Research interests

Publications

• The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

  Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2021.11.003

• PD-L1 as a biomarker of response to immune-checkpoint inhibitors

  Nature Reviews Clinical Oncology · 2021 · 10.1038/s41571-021-00473-5

• IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

  Journal of Thoracic Oncology · 2020 · https://doi.org/10.1016/j.jtho.2020.01.005

• A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

  Journal of Thoracic Oncology · 2020 · 10.1016/j.jtho.2020.06.001

• PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.05.013

• Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2017.12.001

• Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

  Archives of Pathology & Laboratory Medicine · 2018 · https://doi.org/10.5858/arpa.2017-0388-cp

• Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

  Journal of Thoracic Oncology · 2018 · 10.1016/j.jtho.2018.12.005

• Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

  Nature Genetics · 2017 · 10.1038/ng.3892

• The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

  Journal of Thoracic Oncology · 2017 · 10.1016/j.jtho.2017.04.011

• PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

  Journal of Thoracic Oncology · 2016 · 10.1016/j.jtho.2016.11.2228

• The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

  Journal of Thoracic Oncology · 2016 · https://doi.org/10.1016/j.jtho.2015.09.009

• The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

  Journal of Thoracic Oncology · 2016 · 10.1016/j.jtho.2016.03.025

• The 2015 World Health Organization Classification of Lung Tumors

  Journal of Thoracic Oncology · 2015 · https://doi.org/10.1097/jto.0000000000000630

• Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids

  Nature Medicine · 2015 · 10.1038/nm.3973

• Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1214726

• Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

  Archives of Pathology & Laboratory Medicine · 2012 · 10.5858/arpa.2012-0263-ra

• Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

  Nature · 2012 · https://doi.org/10.1038/nature11547

• EGFR Mutations and Lung Cancer

  Annual Review of Pathology Mechanisms of Disease · 2011 · 10.1146/annurev-pathol-011110-130206

• An overview of the c-MET signaling pathway

  Therapeutic Advances in Medical Oncology · 2011 · 10.1177/1758834011422556

• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  Journal of Thoracic Oncology · 2011 · https://doi.org/10.1097/jto.0b013e318206a221

• The landscape of somatic copy-number alteration across human cancers

  Nature · 2010 · https://doi.org/10.1038/nature08822

• SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

  Nature Genetics · 2009 · 10.1038/ng.465

• Characterizing the cancer genome in lung adenocarcinoma

  Nature · 2007 · 10.1038/nature06358

• Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

  New England Journal of Medicine · 2005 · 10.1056/nejmoa043623

• Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

  New England Journal of Medicine · 2005 · 10.1056/nejmoa050736

• Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

  Nature · 2000 · 10.1038/35017574

Current projects

No projects listed.